Viewing StudyNCT00246246



Ignite Creation Date: 2024-05-05 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00246246
Status: COMPLETED
Last Update Posted: 2011-02-11
First Post: 2005-10-28

Brief Title: A Randomized Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
Sponsor: Janssen-Ortho Inc Canada
Organization: Janssen-Ortho Inc Canada

Organization Data

Organization: Janssen-Ortho Inc Canada
Class: INDUSTRY
Study ID: CR005818
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Janssen-Ortho Inc Canada
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators